Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.

Nettiksimmons J, Beckett L, Schwarz C, Carmichael O, Fletcher E, Decarli C.

Psychol Aging. 2013 Mar;28(1):191-201. doi: 10.1037/a0031063.

2.

The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.

Murray AD, Staff RT, McNeil CJ, Salarirad S, Ahearn TS, Mustafa N, Whalley LJ.

Brain. 2011 Dec;134(Pt 12):3687-96. doi: 10.1093/brain/awr259. Epub 2011 Nov 18.

3.

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.

Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.

4.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

5.

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2010 Feb 10;30(6):2088-101. doi: 10.1523/JNEUROSCI.3785-09.2010.

6.

A data-driven model of biomarker changes in sporadic Alzheimer's disease.

Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, Schott JM, Alexander DC; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2014 Sep;137(Pt 9):2564-77. doi: 10.1093/brain/awu176. Epub 2014 Jul 9.

7.

Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.

Glodzik L, Mosconi L, Tsui W, de Santi S, Zinkowski R, Pirraglia E, Rich KE, McHugh P, Li Y, Williams S, Ali F, Zetterberg H, Blennow K, Mehta P, de Leon MJ.

Neurobiol Aging. 2012 Jul;33(7):1215-27. doi: 10.1016/j.neurobiolaging.2011.02.012. Epub 2011 May 6.

8.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

9.

Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?

Brickman AM, Muraskin J, Zimmerman ME.

Dialogues Clin Neurosci. 2009;11(2):181-90.

10.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Jul 28;73(4):294-301. doi: 10.1212/WNL.0b013e3181af79fb.

11.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
12.

Vascular burden and Alzheimer disease pathologic progression.

Lo RY, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 Sep 25;79(13):1349-55. Epub 2012 Sep 12.

13.

CSF Apo-E levels associate with cognitive decline and MRI changes.

Toledo JB, Da X, Weiner MW, Wolk DA, Xie SX, Arnold SE, Davatzikos C, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol. 2014 May;127(5):621-32. doi: 10.1007/s00401-013-1236-0. Epub 2014 Jan 3.

14.

The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.

Frisoni GB, Henneman WJ, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund LO, Zito G, Rossini PM, Winblad B, Barkhof F; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2008 Jul;4(4):255-64. doi: 10.1016/j.jalz.2008.04.009.

15.

Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

DeCarli C.

J Alzheimers Dis. 2013;33 Suppl 1:S417-26. doi: 10.3233/JAD-2012-129004. Review.

16.

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

Schott JM, Bartlett JW, Fox NC, Barnes J; Alzheimer's Disease Neuroimaging Initiative Investigators.

Ann Neurol. 2010 Dec;68(6):825-34. doi: 10.1002/ana.22315.

PMID:
21181717
17.

Longitudinal volumetric MRI change and rate of cognitive decline.

Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC.

Neurology. 2005 Aug 23;65(4):565-71.

18.

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.

Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Apr 15;45(3):645-55.

19.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

20.

Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease.

Lee DY, Fletcher E, Martinez O, Zozulya N, Kim J, Tran J, Buonocore M, Carmichael O, DeCarli C.

Stroke. 2010 Aug;41(8):1791-7. doi: 10.1161/STROKEAHA.110.582163. Epub 2010 Jul 1.

Items per page

Supplemental Content

Write to the Help Desk